Loading clinical trials...
Loading clinical trials...
A Single Dose, Comparative Bioavailability Study of Two Formulations of Famciclovir 500 mg Tablets Under Non-Fasting Conditions
Conditions
Interventions
Famciclovir 500 mg Tablets
Famvir® 500 mg Tablets
Locations
2
United States
Gateway Medical Research, Inc.
Saint Charles, Missouri, United States
Ba Research Co.
Toronto, Ontario, Canada
Start Date
August 1, 2004
Primary Completion Date
September 1, 2004
Completion Date
September 1, 2004
Last Updated
August 20, 2024
NCT06716502
NCT00090662
NCT06290258
NCT07310264
NCT07483606
NCT06342713
Lead Sponsor
Teva Pharmaceuticals USA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions